retatrutide fda approval date Is Approved? Status and Safety Demand for Unapproved Weight-Loss Drug

Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022

The brand states that taking two or three capsules is "safe, but unnecessary." This article did not independently verify that higher-dose safety claim, and you should follow the labeled serving directions unless a healthcare professional advises otherwise

An earlier study of 2,000 overweight adults compared people who took Semaglutide GLP-1 plus a diet and exercise program with people who made the same lifestyle changes but didnt take Semaglutide GLP-1

We see in clinical trials that theres a variation in the amount of weight someone loses, a variation in their appetite and a variation in unwanted side effects, says Dr